Imaging & Diagnostics

Targeting somatostatin receptor-positive tumors of the foregut, midgut, and hindgut, Bexlutry utilizes lutetium-177 to deliver localized radiation directly to malignant cells. This recent approval by the U.S. Food and Drug Administration (FDA) represents a significant shift for Curium as it

Targeted radiopharmaceutical therapies ensure that radioactive agents are delivered directly to malignant cells while minimizing collateral damage to healthy tissue. The appointment of Dr. Amir Iravani as the Director of the Theranostics Program and Vice Chair of Clinical Research at UCLA Health

Many Fitbit Air users find that Google Health’s inability to display a simple history of past metrics makes it difficult to track long-term progress compared to the calendar-based navigation in Bevel. This limitation highlights a growing frustration among fitness enthusiasts who prioritize data

Urologists are increasingly looking toward theranostics to resolve the clinical dilemma of equivocal MRI findings that currently lead to a high volume of redundant tissue samplings. This shift reflects a broader commitment to precision medicine, where the objective is to replace invasive,

Medical professionals currently face the challenge of transporting unstable stroke patients to radiology suites, a hurdle that portable electromagnetic imaging is designed to solve. EMvision Medical Devices has emerged as a leader in this transition, moving neurological diagnostics from heavy,

Traditional liver biopsies often fail to capture the full picture of organ health, leading to sampling errors that can result in the unnecessary discard of viable donor livers. This invasive procedure provides only a microscopic glimpse into a large and complex organ, often missing localized